Is Your Medical Device Company Ready for the New Normal?

© 2022 D2Creative. All Rights Reserved. Privacy Policy

D2 Creative Logo
D2 Creative Logo

As medical device companies rush to meet the new demands of clinicians and patients, we want your company to be prepared.

When it comes to marketing and sales, today’s world is as full of uncertainty as it is potential.

The dust is settling from the early days of the pandemic while chronic diseases and elective procedures are on the rise.

The medical device and medical supplies markets are well-positioned for a boost in medical device sales, but many companies are struggling to capitalize on it as they find their footing in a vastly different world. But within this strange new marketing landscape is an unprecedented opportunity for innovation, and in this white paper we plan to show it to you.

The healthcare industry isn’t waiting, so neither should you. Download your copy of the white paper.

By submitting the form, you authorize D2 Creative to add you to our email list. You may unsubscribe at any time using the link inside the emails.

Get The White Paper

In this white paper, you’ll find:

  • A look at the current medical device market size and industry analysis, along with specific effects from the COVID-19 pandemic

  • The challenges and limitations today’s sales reps face as they market their products in a remote world

  • How you can capitalize on post-pandemic opportunities, educate clinicians and reps from anywhere, and get your devices in the hands of the people who need them

Effect of the COVID-19 Pandemic on Medical Device Markets: Challenges Facing Salesforces in the New Normal and How to Forge Ahead with Confidence

Whitepaper Cover

Download our new white paper for medical device industry analysis, market insights, projections, consumer preferences, and fresh perspectives you’re sure to find useful.

of pharma and medical product decision makers feel the new selling models are the same or more effective than they were compared to previous models, while 88% believed the model could be sustained for at least a year beyond the pandemic.

84%

McKinsey & Company

Healthcare Provider Post-Pandemic Meeting Preferences (%), 2021 

Source: Accenture